What Women at Josie Are Choosing At Josie, youll talk through the options with your provider based on your goals, health history, and preferences
GLP1 medications produce the kind of significant, sustained weight loss (15 to 25 percent of body weight in clinical trials) that was previously achievable only through bariatric surgery
The FDA has not approved compounded GLP-1 formulations, yet research on branded GLP-1 agonists identifies consistent interaction patterns that apply across all GLP-1 receptor agonists regardless of source
That rules out, straightforwardly, radioligand or fluorescent binding assays, competition binding against a known ligand, recombinant receptor-expressing lines, functional readouts tied to a defined coupling pathway, and antagonist controls to demonstrate that an effect is receptor-mediated
In an OIS model induced by Nras G12v overexpression in hepatocytes of immunodeficient Nod Scid Gamma (NSG) mice, senescent cells were successfully eliminated when treated with the anti-uPAR CAR-T cells